GIST is an acquired function mutation of c-KIT and platelet-derived growth factor receptor alpha (PDGFRA), so the advent of tyrosine kinase inhibitors (TKIs) has revolutionized the treatment regimen for GISTs (8, 9). Here, PDGFRA is linked to gastrointestinal stromal tumor.